Hohimer Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-10,641
Closed -$2.32M 243
2024
Q1
$2.32M Sell
10,641
-73
-0.7% -$16.1K 0.54% 70
2023
Q4
$2.44M Buy
10,714
+133
+1% +$27.9K 0.62% 54
2023
Q3
$2.13M Sell
10,581
-2,041
-16% -$430K 0.61% 61
2023
Q2
$2.62M Sell
12,622
-458
-4% -$88.8K 0.72% 54
2023
Q1
$2.58M Buy
13,080
+2,375
+22% +$489K 0.75% 50
2022
Q4
$2.17M Sell
10,705
-2,412
-18% -$471K 0.69% 45
2022
Q3
$2.31M Buy
13,117
+214
+2% +$43.8K 0.74% 61
2022
Q2
$2.6M Sell
12,903
-8,405
-39% -$1.79M 0.77% 57
2022
Q1
$4.83M Buy
21,308
+625
+3% +$147K 0.95% 27
2021
Q4
$5.58M Sell
20,683
-1,289
-6% -$319K 1.18% 19
2021
Q3
$5.31M Sell
21,972
-444
-2% -$112K 1.11% 20
2021
Q2
$5.31M Buy
22,416
+736
+3% +$168K 1.09% 22
2021
Q1
$4.75M Buy
21,680
+1,574
+8% +$316K 1.16% 20
2020
Q4
$3.52M Buy
20,106
+202
+1% +$34.9K 0.93% 27
2020
Q3
$3.42M Buy
+19,904
New +$3.15M 0.97% 25

Other funds holding LH

Hohimer Wealth Management's LH Position: Q2 2024 in Review

Hohimer Wealth Management sold out of Labcorp (LH) in Q2 2024, closing a stake of 10,641 shares — an estimated $2.32M sold.

Hohimer Wealth Management first reported a position in LH in Q3 2020 and held it in 15 quarters. The position peaked at $5.58M in Q4 2021. 853 funds tracked by Wall St. Rank hold LH as of Q2 2024.

  • Hohimer Wealth Management reported no remaining Labcorp position as of Q2 2024 after selling out during the quarter.
  • Hohimer Wealth Management sold 10,641 Labcorp shares in Q2 2024, an estimated $2.32M.
  • Hohimer Wealth Management first reported a position in Labcorp in Q3 2020 and held it in 15 quarters.
  • Hohimer Wealth Management's Labcorp position peaked at $5.58M in Q4 2021.
  • 853 funds tracked by Wall St. Rank held Labcorp as of Q2 2024.

Based on Hohimer Wealth Management's 13F filing for Q2 2024, filed 2 Aug 2024.